{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:20:13Z","timestamp":1773271213554,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,2,28]],"date-time":"2015-02-28T00:00:00Z","timestamp":1425081600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"The Familien Hede Nielsens Foundation","award":["ID0E2PAE1655"],"award-info":[{"award-number":["ID0E2PAE1655"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s10549-015-3313-7","type":"journal-article","created":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T19:28:48Z","timestamp":1429644528000},"page":"289-298","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Splicing analysis of 14 BRCA1 missense variants classifies nine variants as pathogenic"],"prefix":"10.1007","volume":"150","author":[{"given":"Lise B.","family":"Ahlborn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mette","family":"Dandanell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ane Y.","family":"Steffensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"J\u00f8nson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Finn C.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas v. O.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,28]]},"reference":[{"issue":"5","key":"3313_CR1","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117\u20131130","journal-title":"Am J Hum Genet"},{"issue":"5645","key":"3313_CR2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"MC King","year":"2003","unstructured":"King MC, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643\u2013646","journal-title":"Science"},{"issue":"3","key":"3313_CR3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10549-010-0805-3","volume":"124","author":"DM Kolk van der","year":"2010","unstructured":"van der Kolk DM, de Bock GH, Leegte BK et al (2010) Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age. Breast Cancer Res Treat 124(3):643\u2013651","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"3313_CR4","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnci\/djt095","volume":"105","author":"N Mavaddat","year":"2013","unstructured":"Mavaddat N, Peock S, Frost D et al (2013) Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst 105(11):812\u2013822","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"3313_CR5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/humu.21628","volume":"33","author":"AB Spurdle","year":"2012","unstructured":"Spurdle AB, Healey S, Devereau A et al (2012) ENIGMA\u2013evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes. Hum Mutat 33(1):2\u20137","journal-title":"Hum Mutat"},{"issue":"4","key":"3313_CR6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1086\/424388","volume":"75","author":"DE Goldgar","year":"2004","unstructured":"Goldgar DE, Easton DF, Deffenbaugh AM, Monteiro AN, Tavtigian SV, Couch FJ (2004) Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2. Am J Hum Genet 75(4):535\u2013544","journal-title":"Am J Hum Genet"},{"issue":"6","key":"3313_CR7","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1158\/1078-0432.CCR-09-2564","volume":"16","author":"DJ Sanz","year":"2010","unstructured":"Sanz DJ, Acedo A, Infante M et al (2010) A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast\/ovarian cancer patients. Clin Cancer Res 16(6):1957\u20131967","journal-title":"Clin Cancer Res"},{"issue":"7","key":"3313_CR8","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/jmg.2007.056895","volume":"45","author":"C Bonnet","year":"2008","unstructured":"Bonnet C, Krieger S, Vezain M et al (2008) Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene. J Med Genet 45(7):438\u2013446","journal-title":"J Med Genet"},{"issue":"10","key":"3313_CR9","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/ejhg.2011.100","volume":"19","author":"JC Thery","year":"2011","unstructured":"Thery JC, Krieger S, Gaildrat P et al (2011) Contribution of bioinformatics predictions and functional splicing assays to the interpretation of unclassified variants of the BRCA genes. Eur J Hum Genet 19(10):1052\u20131058","journal-title":"Eur J Hum Genet"},{"issue":"12","key":"3313_CR10","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/ejhg.2014.40","volume":"22","author":"AY Steffensen","year":"2014","unstructured":"Steffensen AY, Dandanell M, Jonson L et al (2014) Functional characterization of BRCA1 gene variants by mini-gene splicing assay. Eur J Hum Genet 22(12):1362\u20131368","journal-title":"Eur J Hum Genet"},{"issue":"12","key":"3313_CR11","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1158\/0008-5472.CAN-09-4563","volume":"70","author":"MS Lee","year":"2010","unstructured":"Lee MS, Green R, Marsillac SM et al (2010) Comprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assays. Cancer Res 70(12):4880\u20134890","journal-title":"Cancer Res"},{"issue":"7","key":"3313_CR12","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jmg.2003.015867","volume":"41","author":"V Abkevich","year":"2004","unstructured":"Abkevich V, Zharkikh A, Deffenbaugh AM et al (2004) Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation. J Med Genet 41(7):492\u2013507","journal-title":"J Med Genet"},{"issue":"2","key":"3313_CR13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1006\/jmbi.2001.4510","volume":"307","author":"D Chasman","year":"2001","unstructured":"Chasman D, Adams RM (2001) Predicting the functional consequences of non-synonymous single nucleotide polymorphisms: structure-based assessment of amino acid variation. J Mol Biol 307(2):683\u2013706","journal-title":"J Mol Biol"},{"issue":"4","key":"3313_CR14","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1158\/0008-5472.CAN-05-3546","volume":"66","author":"G Chenevix-Trench","year":"2006","unstructured":"Chenevix-Trench G, Healey S, Lakhani S et al (2006) Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance. Cancer Res 66(4):2019\u20132027","journal-title":"Cancer Res"},{"issue":"1","key":"3313_CR15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/jmg.2005.033258","volume":"43","author":"PK Lovelock","year":"2006","unstructured":"Lovelock PK, Healey S, Au W et al (2006) Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants. J Med Genet 43(1):74\u201383","journal-title":"J Med Genet"},{"issue":"5182","key":"3313_CR16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266(5182):66\u201371","journal-title":"Science"},{"issue":"2","key":"3313_CR17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/1098-1004(200008)16:2<123::AID-HUMU4>3.0.CO;2-Y","volume":"16","author":"C Szabo","year":"2000","unstructured":"Szabo C, Masiello A, Ryan JF, Brody LC (2000) The breast cancer information core: database design, structure, and scope. Hum Mutat 16(2):123\u2013131","journal-title":"Hum Mutat"},{"issue":"6","key":"3313_CR18","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.20.6.1480","volume":"20","author":"TS Frank","year":"2002","unstructured":"Frank TS, Deffenbaugh AM, Reid JE et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20(6):1480\u20131490","journal-title":"J Clin Oncol"},{"issue":"8","key":"3313_CR19","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/embor.2009.170","volume":"10","author":"D Baralle","year":"2009","unstructured":"Baralle D, Lucassen A, Buratti E (2009) Missed threads. The impact of pre-mRNA splicing defects on clinical practice. EMBO Rep 10(8):810\u2013816","journal-title":"EMBO Rep"},{"key":"3313_CR20","unstructured":"Exome Aggregation Consortium (ExAC), Cambridge http:\/\/exac.broadinstitute.org"},{"issue":"2","key":"3313_CR21","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1371\/journal.pcbi.0030026","volume":"3","author":"R Karchin","year":"2007","unstructured":"Karchin R, Monteiro AN, Tavtigian SV, Carvalho MA, Sali A (2007) Functional impact of missense variants in BRCA1 predicted by supervised learning. PLoS Comput Biol 3(2):e26","journal-title":"PLoS Comput Biol"},{"issue":"26","key":"3313_CR22","doi-asserted-by":"crossref","first-page":"20080","DOI":"10.1074\/jbc.M109.088922","volume":"285","author":"PJ Rowling","year":"2010","unstructured":"Rowling PJ, Cook R, Itzhaki LS (2010) Toward classification of BRCA1 missense variants using a biophysical approach. J Biol Chem 285(26):20080\u201320087","journal-title":"J Biol Chem"},{"key":"3313_CR23","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1002\/humu.1380110163","volume":"1","author":"JT Bergthorsson","year":"1998","unstructured":"Bergthorsson JT, Jonasdottir A, Johannesdottir G et al (1998) Identification of a novel splice-site mutation of the BRCA1 gene in two breast cancer families: screening reveals low frequency in Icelandic breast cancer patients. Hum Mutat Suppl 1:S195\u2013S197","journal-title":"Hum Mutat Suppl"},{"issue":"4","key":"3313_CR24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/hmg\/10.4.353","volume":"10","author":"J Vallon-Christersson","year":"2001","unstructured":"Vallon-Christersson J, Cayanan C, Haraldsson K et al (2001) Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families. Hum Mol Genet 10(4):353\u2013360","journal-title":"Hum Mol Genet"},{"issue":"3","key":"3313_CR25","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s10549-011-1674-0","volume":"132","author":"M Thomassen","year":"2012","unstructured":"Thomassen M, Blanco A, Montagna M et al (2012) Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members. Breast Cancer Res Treat 132(3):1009\u20131023","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"3313_CR26","doi-asserted-by":"crossref","first-page":"e50800","DOI":"10.1371\/journal.pone.0050800","volume":"7","author":"B Wappenschmidt","year":"2012","unstructured":"Wappenschmidt B, Becker AA, Hauke J et al (2012) Analysis of 30 putative BRCA1 splicing mutations in hereditary breast and ovarian cancer families identifies exonic splice site mutations that escape in silico prediction. PLoS One 7(12):e50800","journal-title":"PLoS One"},{"issue":"8","key":"3313_CR27","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/humu.22101","volume":"33","author":"C Houdayer","year":"2012","unstructured":"Houdayer C, Caux-Moncoutier V, Krieger S et al (2012) Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico\/in vitro studies on BRCA1 and BRCA2 variants. Hum Mutat 33(8):1228\u20131238","journal-title":"Hum Mutat"},{"issue":"1","key":"3313_CR28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/prot.21188","volume":"66","author":"CA Gough","year":"2007","unstructured":"Gough CA, Gojobori T, Imanishi T (2007) Cancer-related mutations in BRCA1-BRCT cause long-range structural changes in protein-protein binding sites: a molecular dynamics study. Proteins 66(1):69\u201386","journal-title":"Proteins"},{"issue":"2","key":"3313_CR29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/jhg.2011.142","volume":"57","author":"WH Kuo","year":"2012","unstructured":"Kuo WH, Lin PH, Huang AC et al (2012) Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancer. J Hum Genet 57(2):130\u2013138","journal-title":"J Hum Genet"},{"issue":"6","key":"3313_CR30","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nsmb776","volume":"11","author":"RS Williams","year":"2004","unstructured":"Williams RS, Lee MS, Hau DD, Glover JN (2004) Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1. Nat Struct Mol Biol 11(6):519\u2013525","journal-title":"Nat Struct Mol Biol"},{"issue":"5","key":"3313_CR31","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1086\/521032","volume":"81","author":"DF Easton","year":"2007","unstructured":"Easton DF, Deffenbaugh AM, Pruss D et al (2007) A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Am J Hum Genet 81(5):873\u2013883","journal-title":"Am J Hum Genet"},{"issue":"2","key":"3313_CR32","doi-asserted-by":"crossref","first-page":"e57173","DOI":"10.1371\/journal.pone.0057173","volume":"8","author":"M Colombo","year":"2013","unstructured":"Colombo M, De Vecchi G, Caleca L et al (2013) Comparative in vitro and in silico analyses of variants in splicing regions of BRCA1 and BRCA2 genes and characterization of novel pathogenic mutations. PLoS One 8(2):e57173","journal-title":"PLoS One"},{"issue":"14","key":"3313_CR33","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1093\/hmg\/ddu075","volume":"23","author":"M Colombo","year":"2014","unstructured":"Colombo M, Blok MJ, Whiley P et al (2014) Comprehensive annotation of splice junctions supports pervasive alternative splicing at the BRCA1 locus: a report from the ENIGMA consortium. Hum Mol Genet 23(14):3666\u20133680","journal-title":"Hum Mol Genet"},{"issue":"11","key":"3313_CR34","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/humu.20901","volume":"29","author":"AB Spurdle","year":"2008","unstructured":"Spurdle AB, Couch FJ, Hogervorst FB, Radice P, Sinilnikova OM (2008) Prediction and assessment of splicing alterations: implications for clinical testing. Hum Mutat 29(11):1304\u20131313","journal-title":"Hum Mutat"},{"issue":"10","key":"3313_CR35","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/humu.22388","volume":"34","author":"LC Walker","year":"2013","unstructured":"Walker LC, Whiley PJ, Houdayer C et al (2013) Evaluation of a 5-tier scheme proposed for classification of sequence variants using bioinformatic and splicing assay data: inter-reviewer variability and promotion of minimum reporting guidelines. Hum Mutat 34(10):1424\u20131431","journal-title":"Hum Mutat"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3313-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-015-3313-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3313-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T22:52:58Z","timestamp":1553640778000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-015-3313-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,28]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["3313"],"URL":"https:\/\/doi.org\/10.1007\/s10549-015-3313-7","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,28]]}}}